Skip to main content
Erschienen in: Current Cardiology Reports 6/2015

01.06.2015 | Echocardiography (JM Gardin, Section Editor)

Echocardiographic Evaluation of Prosthetic Heart Valves

verfasst von: Haïfa Mahjoub, Philippe Pibarot, Jean-Gaston Dumesnil

Erschienen in: Current Cardiology Reports | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

The specific flow pattern and imaging features of prosthetic heart valves poses major challenges for the Doppler echocardiographic assessment of prosthetic valve structure and function. A comprehensive approach that integrates several semi-quantitative and quantitative parameters obtained from multiple views is key to appropriately detect and quantitate prosthetic valve dysfunction and complications. In patients with prosthetic valves, and particularly in those with mitral prostheses, transesophageal echocardiography is often required to confirm and/or complement information obtained by transthoracic echocardiography. Three-dimensional echocardiography may provide incremental information for the identification of the underlying etiology of prosthetic valve stenosis or regurgitation. Transcatheter aortic valve implantation has rapidly expanded in the past 10 years and paravalvular regurgitation is frequent following this procedure. Given that paravalvular regurgitant jets are often multiple, irregular, and eccentric, the grading of this type of regurgitation is particularly challenging and requires an integrative multiwindow, multiplane, multiparametric approach.
Literatur
1.
Zurück zum Zitat Yacoub MH, Takkenberg JJ. Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med. 2005;2:60–1.PubMed Yacoub MH, Takkenberg JJ. Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med. 2005;2:60–1.PubMed
2.
Zurück zum Zitat Fanning JP, Platts DG, Walters DL, Fraser JF. Transcatheter aortic valve implantation (TAVI): valve design and evolution. Int J Cardiol. 2013;168:1822–31.PubMed Fanning JP, Platts DG, Walters DL, Fraser JF. Transcatheter aortic valve implantation (TAVI): valve design and evolution. Int J Cardiol. 2013;168:1822–31.PubMed
3.••
Zurück zum Zitat Zoghbi WA, Chambers JB, Dumesnil JG, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography’s Guidelines and Standards Committee and the Task Force on Prosthetic Valves. J Am Soc Echocardiogr. 2009;22:975–1014. quiz 1082–4. This article represents the most recent guidelines of the American Society of Echocardiography for the Doppler-echocardiographic assessment of prosthetic valves. Zoghbi WA, Chambers JB, Dumesnil JG, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography’s Guidelines and Standards Committee and the Task Force on Prosthetic Valves. J Am Soc Echocardiogr. 2009;22:975–1014. quiz 1082–4. This article represents the most recent guidelines of the American Society of Echocardiography for the Doppler-echocardiographic assessment of prosthetic valves.
4.
Zurück zum Zitat Bach DS. Transesophageal echocardiographic (TEE) evaluation of prosthetic valves. Cardiol Clin. 2000;18:751–71.PubMed Bach DS. Transesophageal echocardiographic (TEE) evaluation of prosthetic valves. Cardiol Clin. 2000;18:751–71.PubMed
5.
Zurück zum Zitat Gerstein NS, Copeland SG, Kratzert WB, Deriy L, Windsor J. Now you see it, now you don’t: 3D echocardiographic evaluation of a prosthetic aortic valve. J Cardiothorac Vasc Anesth. 2013;27:1060–3.PubMed Gerstein NS, Copeland SG, Kratzert WB, Deriy L, Windsor J. Now you see it, now you don’t: 3D echocardiographic evaluation of a prosthetic aortic valve. J Cardiothorac Vasc Anesth. 2013;27:1060–3.PubMed
6.•
Zurück zum Zitat Muratori M, Montorsi P, Maffessanti F, et al. Dysfunction of bileaflet aortic prosthesis: accuracy of echocardiography versus fluoroscopy. J Am Coll Cardiol Img. 2013;6:196–205. This study shows that the difference between measured EOA and normal reference EOA as well as the ratio of acceleration time to LV ejection time are the most useful Doppler-echocardiographic parameters to identify prosthetic valve stenosis. Muratori M, Montorsi P, Maffessanti F, et al. Dysfunction of bileaflet aortic prosthesis: accuracy of echocardiography versus fluoroscopy. J Am Coll Cardiol Img. 2013;6:196–205. This study shows that the difference between measured EOA and normal reference EOA as well as the ratio of acceleration time to LV ejection time are the most useful Doppler-echocardiographic parameters to identify prosthetic valve stenosis.
7.
Zurück zum Zitat Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation. 2009;119:1034–48.CrossRefPubMed Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation. 2009;119:1034–48.CrossRefPubMed
8.
Zurück zum Zitat Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation. 2007;115:2856–64.CrossRefPubMed Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation. 2007;115:2856–64.CrossRefPubMed
9.•
Zurück zum Zitat Zamorano JL, Badano LP, Bruce C, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J. 2011;32:2189–214. This paper presents the recommendations of the European Association of Echocardiography and American Society of Echocardiography for the Doppler-echocardiographic assessment of transcatheter heart valves and devices.PubMed Zamorano JL, Badano LP, Bruce C, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J. 2011;32:2189–214. This paper presents the recommendations of the European Association of Echocardiography and American Society of Echocardiography for the Doppler-echocardiographic assessment of transcatheter heart valves and devices.PubMed
10.•
Zurück zum Zitat Evin M, Pibarot P, Guivier-Curien C, Tanne D, Kadem L, Rieu R. Localized transvalvular pressure gradients in mitral bileaflet mechanical heart valves and impact on gradient overestimation by Doppler. J Am Soc Echocardiogr. 2013;26:791–800. This in vitro study provides some new insights regarding the localization and magnitude of the localized high velocities within the central orifice of mitral bileaflet mechanical valves.PubMed Evin M, Pibarot P, Guivier-Curien C, Tanne D, Kadem L, Rieu R. Localized transvalvular pressure gradients in mitral bileaflet mechanical heart valves and impact on gradient overestimation by Doppler. J Am Soc Echocardiogr. 2013;26:791–800. This in vitro study provides some new insights regarding the localization and magnitude of the localized high velocities within the central orifice of mitral bileaflet mechanical valves.PubMed
11.
Zurück zum Zitat Pibarot P, Dumesnil JG. Doppler echocardiographic evaluation of prosthetic valve function. Heart. 2012;98:69–78.CrossRefPubMed Pibarot P, Dumesnil JG. Doppler echocardiographic evaluation of prosthetic valve function. Heart. 2012;98:69–78.CrossRefPubMed
12.
Zurück zum Zitat Smadi O, Garcia J, Pibarot P, Gaillard E, Hassan I, Kadem L. Accuracy of Doppler-echocardiographic parameters for the detection of aortic bileaflet mechanical prosthetic valve dysfunction. Eur Heart J Cardiovasc Imaging. 2014;15:142–51 Smadi O, Garcia J, Pibarot P, Gaillard E, Hassan I, Kadem L. Accuracy of Doppler-echocardiographic parameters for the detection of aortic bileaflet mechanical prosthetic valve dysfunction. Eur Heart J Cardiovasc Imaging. 2014;15:142–51
13.
Zurück zum Zitat Ben Zekry S, Saad RM, Ozkan M, et al. Flow acceleration time and ratio of acceleration time to ejection time for prosthetic aortic valve function. J Am Coll Cardiol Img. 2011;4:1161–70. Ben Zekry S, Saad RM, Ozkan M, et al. Flow acceleration time and ratio of acceleration time to ejection time for prosthetic aortic valve function. J Am Coll Cardiol Img. 2011;4:1161–70.
14.
Zurück zum Zitat Mahjoub H, Mathieu P, Senechal M, et al. ApoB/ApoA-I ratio is associated with increased risk of bioprosthetic valve degeneration. J Am Coll Cardiol. 2013;61:752–61.PubMed Mahjoub H, Mathieu P, Senechal M, et al. ApoB/ApoA-I ratio is associated with increased risk of bioprosthetic valve degeneration. J Am Coll Cardiol. 2013;61:752–61.PubMed
15.
Zurück zum Zitat Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol. 2009;54:2251–60.PubMed Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol. 2009;54:2251–60.PubMed
16.
Zurück zum Zitat Levy F, Donal E, Biere L, et al. Hemodynamic performance during exercise of the new St. Jude Trifecta aortic bioprosthesis: results from a French multicenter study. J Am Soc Echocardiogr. 2014;27:590–7.PubMed Levy F, Donal E, Biere L, et al. Hemodynamic performance during exercise of the new St. Jude Trifecta aortic bioprosthesis: results from a French multicenter study. J Am Soc Echocardiogr. 2014;27:590–7.PubMed
17.
Zurück zum Zitat Alton ME, Pasierski TJ, Orsinelli DA, Eaton GM, Pearson AC. Comparison of transthoracic and transesophageal echocardiography in evaluation of 47 Starr-Edwards prosthetic valves. J Am Coll Cardiol. 1992;20:1503–11.PubMed Alton ME, Pasierski TJ, Orsinelli DA, Eaton GM, Pearson AC. Comparison of transthoracic and transesophageal echocardiography in evaluation of 47 Starr-Edwards prosthetic valves. J Am Coll Cardiol. 1992;20:1503–11.PubMed
18.
Zurück zum Zitat Daniel LB, Grigg LE, Weisel RD, Rakowski H. Comparison of transthoracic and transesophageal assessment of prosthetic valve dysfunction. Echocardiography. 1990;7:83–95.CrossRefPubMed Daniel LB, Grigg LE, Weisel RD, Rakowski H. Comparison of transthoracic and transesophageal assessment of prosthetic valve dysfunction. Echocardiography. 1990;7:83–95.CrossRefPubMed
19.
Zurück zum Zitat Vitarelli A, Conde Y, Cimino E, et al. Assessment of severity of mechanical prosthetic mitral regurgitation by transoesophageal echocardiography. Heart. 2004;90:539–44.CrossRefPubMedCentralPubMed Vitarelli A, Conde Y, Cimino E, et al. Assessment of severity of mechanical prosthetic mitral regurgitation by transoesophageal echocardiography. Heart. 2004;90:539–44.CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33:2451–96.PubMed Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33:2451–96.PubMed
21.
Zurück zum Zitat Jain S, Malouf JF. Incremental value of 3-D transesophageal echocardiographic imaging of the mitral valve. Curr Cardiol Rep. 2014;16:439.PubMed Jain S, Malouf JF. Incremental value of 3-D transesophageal echocardiographic imaging of the mitral valve. Curr Cardiol Rep. 2014;16:439.PubMed
22.
Zurück zum Zitat Bloomfield GS, Gillam LD, Hahn RT, et al. A practical guide to multimodality imaging of transcatheter aortic valve replacement. J Am Coll Cardiol Img. 2012;5:441–55. Bloomfield GS, Gillam LD, Hahn RT, et al. A practical guide to multimodality imaging of transcatheter aortic valve replacement. J Am Coll Cardiol Img. 2012;5:441–55.
23.•
Zurück zum Zitat Clavel MA, Rodes-Cabau J, Dumont E, et al. Validation and characterization of transcatheter aortic valve effective orifice area measured by Doppler echocardiography. J Am Coll Cardiol Img. 2011;4:1053–62. This is the first validation of the method to measure the EOA of transcatheter aortic valves by Doppler-echocardiography. Clavel MA, Rodes-Cabau J, Dumont E, et al. Validation and characterization of transcatheter aortic valve effective orifice area measured by Doppler echocardiography. J Am Coll Cardiol Img. 2011;4:1053–62. This is the first validation of the method to measure the EOA of transcatheter aortic valves by Doppler-echocardiography.
24.••
Zurück zum Zitat Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg. 2013;145:6–23. This article presents the recommendations for the Doppler-echocardiographic assessment of transcatheter aortic valves.PubMed Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg. 2013;145:6–23. This article presents the recommendations for the Doppler-echocardiographic assessment of transcatheter aortic valves.PubMed
25.••
Zurück zum Zitat Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61:1585–95. This meta-analysis reports the prevalence and impact on prognosis of paravalvular regurgitation following TAVI.PubMed Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61:1585–95. This meta-analysis reports the prevalence and impact on prognosis of paravalvular regurgitation following TAVI.PubMed
26.
Zurück zum Zitat Ribeiro HB, Le Ven F, Larose E et al. Cardiac magnetic resonance versus transthoracic echocardiography for the assessment and quantification of aortic regurgitation in patients undergoing transcatheter aortic valve implantation. Heart. 2014;100:1924–32. Ribeiro HB, Le Ven F, Larose E et al. Cardiac magnetic resonance versus transthoracic echocardiography for the assessment and quantification of aortic regurgitation in patients undergoing transcatheter aortic valve implantation. Heart. 2014;100:1924–32.
27.
Zurück zum Zitat Goncalves A, Almeria C, Marcos-Alberca P, et al. Three-dimensional echocardiography in paravalvular aortic regurgitation assessment after transcatheter aortic valve implantation. J Am Soc Echocardiogr. 2012;25:47–55.PubMed Goncalves A, Almeria C, Marcos-Alberca P, et al. Three-dimensional echocardiography in paravalvular aortic regurgitation assessment after transcatheter aortic valve implantation. J Am Soc Echocardiogr. 2012;25:47–55.PubMed
Metadaten
Titel
Echocardiographic Evaluation of Prosthetic Heart Valves
verfasst von
Haïfa Mahjoub
Philippe Pibarot
Jean-Gaston Dumesnil
Publikationsdatum
01.06.2015
Verlag
Springer US
Erschienen in
Current Cardiology Reports / Ausgabe 6/2015
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-015-0602-z

Weitere Artikel der Ausgabe 6/2015

Current Cardiology Reports 6/2015 Zur Ausgabe

Diabetes and Cardiovascular Disease (S Malik, Section Editor)

Update on Blood Pressure Goals in Diabetes Mellitus

Interventional Cardiology (S Rao, Section Editor)

Transradial Sheathless Approach for PCI

Diabetes and Cardiovascular Disease (S Malik, Section Editor)

Impact of Functional Foods on Prevention of Cardiovascular Disease and Diabetes

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.